Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits. Why do patients stop a therapy that clearly works? In many cases, the answer lies in a mix of side effects, cost, and patient expectations. This article explores early warning …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.